← Eichor
Study identifier: NCT06957015 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size

Condition: Colonic Polyps · CRC (Colorectal Cancer) · Artificial Intelligence (AI)  ·  Sponsor: Chinese University of Hong Kong

PhaseNA
Planned participants278
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Colorectal polyp size is related to the risk of exhibiting advanced histological features. Moreover, polyps larger than 10 mm are associated with an elevated risk of metachronous advanced neoplasia and colorectal cancer (CRC). Consequently, accurate measurement of polyp size, especially at the 10 mm threshold is critical for risk stratification and surveillance intervals. Furthermore, polyp size is also important for the choice of the appropriate resection procedures. Underestimation may lead to delayed diagnosis, thereby increasing the risk of colorectal cancer, while overestimation may result in unnecessary surveillance endoscopies.

This description comes directly from the study's public registry record.

Talk to the study team

Louis HS Lau, FRCP  ·  26370428  ·  louishslau@cuhk.edu.hk

Felix Sia, MSc  ·  852-2637-0428  ·  felixsia@cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Prince of Wales HospitalShatin, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06957015